15:56 Dec 05

Lasa Supergenerics Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
9.92
-0.09 (-0.90%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lasa Supergenerics Ltd. Financials

Lasa Supergenerics Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
9.92
-0.09 (-0.90%)
15:56 Dec 05
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

29/100
Expensive Valuation

Technical

36/100
Technically Neutral

Strength

5

Weakness

7

Opportunity

0

Threats

0

-17.62 %

ROE %

-14.53 %

ROA %

-7.22

EPS

16.71

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
137.13 129.57 104.34 142.45 95.29
Operating Expenses +
121.49 136.16 102.17 136.18 95.57
Raw Material
94.46 110.12 79.28 108.1 75.5
Increase Decrease in Cost
-3.17 -4.01 -4.06 -1.91 -1.45
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
9.93 7.37 6.34 6.11 4.86
Miscellaneous Expenses
32.77 22.68 20.61 23.88 16.66
Operating Profit
15.64 -6.59 2.17 6.27 -0.28
Other Income
0.06 1.8 0.1 5.01 2.67
Depreciation
14 13.42 10.67 12.3 9.84
Interest
0.04 4.16 1.93 2.69 0.73
Profit before tax and exceptio..
1.65 -22.37 -10.34 -3.71 -8.18
Exceptional Items
-7.86 -19.9 -8.77 -15.67 -36.23
PBT
-6.21 -42.27 -19.11 -19.38 28.05
Provision for Taxation
-0.84 -3.64 2.62 -4.63 -8.26
Net Profit
-5.37 -38.62 -21.73 -14.76 -36.17
NET Profit after MI
0 0 0 0 0
EPS
-1.3 -7.71 -4.34 -2.95 -7.22
Operating Profit Margin (%)
11.41 -5.09 2.08 4.4 -0.29
Net Profit Margin (%)
-3.92 -29.81 -20.83 -10.36 -37.96

Lasa Supergenerics Ltd. Shareholding

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 53.60 53.60 53.60 53.60 53.60 53.60
FII 0.00 0.50 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 46.40 45.90 46.40 46.40 46.40 46.40
Shareholder Shares Holding %
Download Our App On: